- How To
- Cigar Info
- Site Info
Currently viewing the tag: "federal-national"
Congress is finishing up the omnibus spending bill. It’s one large bill that provides funding for much of the government. Included in a working version of the bill is language that would exempt premium cigars from FDA control.
According to sources with the International Premium Cigar & Pipe Retailers Association (IPCPR), Congress is currently considering a provision in the agriculture/FDA portion of the appropriations bill that would prevent FDA from using any of its appropria
we are winning the battle against youth and young adult cigarette use. Results for other tobacco products are mixed, and that’s why our truth public education campaign is taking aim at hookah, cigars and other deadly products.
e strongly urge you to oppose the FDA Deeming Authority Clarification Act (HR 2058), a bill that would exempt many tobacco products from the requirements for Food and Drug Administration (FDA) review required by the Family Smoking Prevention and Tobacc
met with White House staff to urge the Administration to move forward with strong U.S. Food and Drug Administration rules to regulate all tobacco products, including cigars and e-cigarettes.
The vapor tobacco industry is calling on the Senate Appropriations Committee to add language to a spending bill that changes the grandfather date for electronic cigarettes and cigars under new rules being finalized by the Food and Drug Administration (FD
In a nationwide survey of U.S. children aged 12 to 17, the Food and Drug Administration’s Center for Tobacco Products has found that among those trying a hookah, electronic cigarette, cigar or regular cigarette for the first time, the numbers who chose t
Regulations Restricting the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Product Packages and Advertisements
Last week, the proposed deeming regulations from FDA were submitted to the White House Office of Management and Budget (OMB) for review. It’s expected to be one of the last steps before FDA’s finalized plans become public and as such law.